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type headache and after postdural puncture, acute dental pain, post-operative, post-traumatic 
and orthopaedic pain.  
Conclusions. Caffeine can manifest a potential effect of analgesia due to its competitive 
antagonism of adenosine receptors at central and peripheral levels as well as modulating pain 
perception and regulating cyclooxygenase-2 transcription.  
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Introduction. Exocrine pancreatic insufficiency (EPI) is characterized by maldigestion of 
nutrients and is caused by insufficient delivery of pancreatic digestive enzymes to the 
duodenum. The fact that the signs and symptoms aren’t specific, results in a late correct 
diagnosis and treatment. The management of EPI consists of taking digestive pancreatic 
enzyme medication during or immediately after the meals. The minimal dosage used when 
starting the therapy is between 40 000 and 50 000 USP units of lipase at each meal. An 
inadequate therapeutic response might be caused by the inactivation of lipase in the gastric acid 
if the medication doesn’t have a gastro-resistant coat.  
Aim of the study. To study the State Medicine Nomenclature and analyze the products suitable 
for treatment of EPI.  
Materials and methods. For this research were used: SNM, latest version including 6133 
medications, international guides for gastrointestinal diseases and scientific articles.   
Results. Out of the 6133 products listed in the SNM, only 25 (0,4%) are drugs that contain 
pancreatic exocrine enzymes. From this 25: 21 (84%) contain only pancreatin, 3 (12%) – 
pancreatin combined with hemicellulose and bovine bile extract and 1 medication (4%) is a 
fusion of pancreatin, hemicellulose, bovine bile extract and simethicone. Only 6 products are 
with mini-microspheres, 16 have a gastro-resistant coat and 3 have an ordinary non-gastro-
resistant coat. According to the producing country, 52% are imported from Germany, 20% - 
from Ukraine, 16% - from Romania, 4% - from Turkey and only 8% are manufactured in 
Republic of Moldova. 5 drugs contain 25 000 USP units of lipase in each tablet/capsule, 6 
products – 10 000 USP units of lipase each tablet and the other 14 medications have between 
8 000 and 3 150 USP units of lipase in each pill. Currently, the following products can’t be 
found on the pharmaceutical market of Republic of Moldova: pancreatin + bile acids + plant 
extracts + antimicrobial constitutive and pancreatin + adsorbent agents.  
Conclusions. The diagnostic and initiation of treatment in patients with exocrine pancreatic 
insufficiency have to be done as soon as possible, in order to prevent the development of 
complications and maintain a high quality of life. The suitable drug and its dose has to be 
chosen for every patient individualy. The capsules with mini-microspheres seem to be the most 
effective from this group of medications, therefore the increase of such drugs would be  
welcomed on the pharmaceutical market of the country. 
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Introduction. The diminishment of immunity, be it congenital or acquired, continues to 
threaten the existence of those who do not have a normal immunity level. Once these sequelae 
are installed, the correction of immune system disorders has become a priority of modern 
medicine, and any action taken to wards the immunocompetent cells certainly needs to be 
carefully studied.  
Aim of the study. The study of the entomological formulant Imupurin properties; the 
evaluation of its specifics and its action properties; and the opportunities of its application in 
the treatment of immune disorders of patients with chronic liver ilnesses.  
Materials and methods. Retrospective study, conducted within the Republican Clinical 
Hospital ”Timofei Moșneaga”, comprises a group of 60 patients, hospitalized in Hepatology 
Unit. The study included the medical records of the patients that have been hospitalized during 
the period of January-august 2014, aged between 40 and 60 years old. The biochemical and 
immunological analyses, as well as the treatment and evolution of these pacients have been 
studied.  
Results. The study has proved that the entomological formulant Imupurin, thanks to its 
components, such as : essential and non-essential amino acids and lipo-proteins, manifests 
special hepatoprotective features and develops a complex immunomodulatory mechanism.This 
contributes to the amount of T- and B-lymphocytes normalization, intensifies phagocytosis 
processes. After treatment with Imupurin, the astheno-vegetative syndrom decreased to 56%, 
the cytolytic syndrome decreased to 31,6 %, the hepato-depressive syndrome reduced to 18 % 
of the patients with chronic vrial hepatites B and C, and the hepatosplenomegaly decreased to 
61 % out of 60 patients.  
Conclusions. The study of the entomological product’s properties in Hepatology Unit proved 
its efficiency in pathological cases of patients with compromised immunity, and specifically, 
it showed immunomodulatory properties that correc the immune state, while its 
hepatoprotective activity induces to a considerable normalization of transaminases and to the 
reduction of hepatomegaly.  
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